Vertex Pharmaceuticals (VRTX) Net Margin (2009 - 2026)
Vertex Pharmaceuticals (VRTX) posted Net Margin of 32.99% for Q2 2026, down 4.47% on a QoQ basis from 34.53% in Q1 2026, and down 185.0% year-over-year from 38.81% in Q2 2025.
Powered by 
Analysis
Vertex Pharmaceuticals (VRTX) Net Margin (2009 - 2026) Analysis & Trends
Vertex Pharmaceuticals has reported Net Margin for 18 years, with the latest figure at 32.99% in Q2 2026.
- On a quarterly basis, Net Margin fell 185.0% year-over-year to 32.99% in Q2 2026; TTM through Jun 2026 was 35.0%, a 314.0% increase from a year earlier, with the FY2025 full-year figure at 32.94%, up 3780.0% from the prior year.
- Net Margin was 32.99% for Q2 2026 at Vertex Pharmaceuticals, down from 34.53% in the prior quarter.
- The five-year high for Net Margin was 41.69% in Q3 2023, with the low at 135.83% in Q2 2024.
- Average Net Margin over 5 years is 25.96%, with a median of 35.95% recorded in 2022.
- The sharpest annual moves came in 2024 and 2025: Net Margin slumped 17256 bps in 2024, then surged 17067 bps in 2025.
- Over 5 years, Net Margin stood at 35.56% in 2022, then increased by 8 bps to 38.48% in 2023, then retreated by 19 bps to 31.35% in 2024, then increased by 19 bps to 37.34% in 2025, then slipped by 12 bps to 32.99% in 2026.
- The last three Net Margin figures came in at 32.99% (Q2 2026), 34.53% (Q1 2026), and 37.34% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | 21.28% |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | -8.05% |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | 22.65% |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | 16.30% |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | -1.58% |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | 32.99% |
| 10 | Bristol Myers Squibb | 124.95 Bn | 113.89 Bn | 9.25 Bn | 25.56% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 32.99% |
| Mar 31, 2026 | 34.53% |
| Dec 31, 2025 | 37.34% |
| Sep 30, 2025 | 35.20% |
| Jun 30, 2025 | 34.84% |
| Mar 31, 2025 | 23.33% |
| Dec 31, 2024 | 31.35% |
| Sep 30, 2024 | 37.71% |
| Jun 30, 2024 | -135.83% |
| Mar 31, 2024 | 40.87% |
| Dec 31, 2023 | 38.48% |
| Sep 30, 2023 | 41.69% |
| Jun 30, 2023 | 36.73% |
| Mar 31, 2023 | 29.47% |
| Dec 31, 2022 | 35.56% |
| Sep 30, 2022 | 39.86% |
| Jun 30, 2022 | 36.90% |
| Mar 31, 2022 | 36.33% |
| Dec 31, 2021 | 37.16% |
| Sep 30, 2021 | 42.94% |
API Access
Vertex Pharmaceuticals Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=VRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "VRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=VRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();